Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer

SIMPLE SUMMARY: Patients with non-small cell lung cancer with an activating EGFR mutation in the tumor, are treated with targeted therapy against this mutation. In the end, all patients develop resistance against this therapy, but some patients have a very short or no benefit. In this study, the aut...

Descripción completa

Detalles Bibliográficos
Autores principales: Steendam, Christi M. J., Veerman, G. D. Marijn, Pruis, Melinda A., Atmodimedjo, Peggy, Paats, Marthe S., van der Leest, Cor, von der Thüsen, Jan H., Yick, David C. Y., Oomen-de Hoop, Esther, Koolen, Stijn L. W., Dinjens, Winand N. M., van Schaik, Ron H. N., Mathijssen, Ron H. J., Aerts, Joachim G. J. V., Dubbink, Hendrikus Jan, Dingemans, Anne-Marie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692448/
https://www.ncbi.nlm.nih.gov/pubmed/33138052
http://dx.doi.org/10.3390/cancers12113179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692448/
https://www.ncbi.nlm.nih.gov/pubmed/33138052
http://dx.doi.org/10.3390/cancers12113179

Ejemplares similares